The Jhunjhunwala family’s wealth in listed firms, which surpassed ₹50,000 crore for the first time in the March quarter, declined by nearly 8% to ₹47,053 crore by the end of the June quarter. Stocks like Titan, Crisil, and Sun Pharma Advanced Research fell between 10% and 35% during this period.
In contrast, Hemendra Kothari’s portfolio gained over 7% , driven by a sharp rally in Alkyl Amines Chemicals and EIH Associated Hotels. However, it remains down 16% from the end of December.
Akash Bhanshali’s portfolio saw a significant gain of over 21% with Sudarshan Chemicals and Ramkrishna Forgings surging 48% and 29%, respectively.
Similarly, the portfolios of Mukul Agrawal, Ashish Dhawan, and Nemish Shah increased by 13%, 14%, and 17%, respectively, in the June quarter, compared to a 3.81% gain in the Nifty index.Among the other biggest gainers is Vijay Kedia, whose portfolio grew by 24% to ₹1,638 crore. His stock Tejas Networks surged 115% in the June quarter, while Atul Auto, Elecon Engineering, and Sudarshan Chemicals rallied between 32% and 48%.Manish Jain’s portfolio also saw a notable gain of 29%, reaching ₹1,592 crore. Three of his stocks – Linde India, Hester Bioscience, and Career Point – rose by 30%, 72%, and 41%, respectively.